BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White PJ. Patient Factors That Influence Warfarin Dose Response. Journal of Pharmacy Practice 2010;23:194-204. [DOI: 10.1177/0897190010362177] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Guidoni CM, Obreli-neto PR, Pereira LRL. Pharmacoepidemiologic study of warfarin prescription in a Brazilian tertiary hospital. J Thromb Thrombolysis 2014;37:542-8. [DOI: 10.1007/s11239-013-1030-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Arendt CJ, Hong JH, Daly RC, Scott C, Mehta RA, Bailey K, Pathak J, Pereira NL. Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery. Am Heart J 2017;187:70-7. [PMID: 28454810 DOI: 10.1016/j.ahj.2017.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Hawkins SC, Caudell MJ, Deloughery TG, Murray W. Participation of Iatrogenically Coagulopathic Patients in Wilderness Activities. Wilderness & Environmental Medicine 2013;24:257-66. [DOI: 10.1016/j.wem.2012.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Khoury G, Sheikh-Taha M. Effect of age and sex on warfarin dosing. Clin Pharmacol 2014;6:103-6. [PMID: 25050078 DOI: 10.2147/CPAA.S66776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Zhang Y, de Boer A, Verhoef TI, van der Meer FJ, Le Cessie S, Maitland-van der Zee AH, Barallon R, de Boer A, Daly A, Maitland-van der Zee A, Redekop K, Stingl J, Manolopoulos VG, Rosendaal FR, Wadelius M. Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands. Thrombosis Research 2015;136:94-100. [DOI: 10.1016/j.thromres.2015.04.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Alshogran OY. Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition. Curr Drug Metab 2019;20:633-45. [PMID: 31267868 DOI: 10.2174/1389200220666190701095807] [Reference Citation Analysis]
7 Smith J, Hanson J, Chowdhury R, Bungard TJ. Community-based management of epistaxis: Who bloody knows? Can Pharm J (Ott) 2019;152:164-76. [PMID: 31156729 DOI: 10.1177/1715163519840380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Gaikwad T, Ghosh K, Kulkarni B, Kulkarni V, Ross C, Shetty S. Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population. European Journal of Pharmacology 2013;710:80-4. [DOI: 10.1016/j.ejphar.2013.04.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
9 Ayesh BM, Abu Shaaban AS, Abed AA. Evaluation of CYP2C9- and VKORC1-based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine. Future Sci OA 2018;4:FSO276. [PMID: 29568565 DOI: 10.4155/fsoa-2017-0112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Winter RL, Sedacca CD, Adams A, Orton EC. Aortic thrombosis in dogs: presentation, therapy, and outcome in 26 cases. J Vet Cardiol 2012;14:333-42. [PMID: 22591640 DOI: 10.1016/j.jvc.2012.02.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
11 Shendre A, Parmar GM, Dillon C, Beasley TM, Limdi NA. Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage. Pharmacotherapy 2018;38:588-96. [PMID: 29393514 DOI: 10.1002/phar.2089] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
12 Ibrahim R, Kucukyazici B, Verter V, Gendreau M, Blostein M. Designing Personalized Treatment: An Application to Anticoagulation Therapy. Prod Oper Manag 2016;25:902-18. [DOI: 10.1111/poms.12514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
13 Alshogran OY, Ocque AJ, Leblond FA, Pichette V, Nolin TD. Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine. J Chromatogr Sci 2016;54:554-60. [PMID: 26657732 DOI: 10.1093/chromsci/bmv186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Daba FB, Tadesse F, Engidawork E. Drug-related problems and potential contributing factors in the management of deep vein thrombosis. BMC Hematol 2016;16:2. [PMID: 26855783 DOI: 10.1186/s12878-016-0043-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Avarello I, Bianchi S, Toschi V, Zighetti ML, Faioni EM. Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity. Thromb Res 2021;203:18-21. [PMID: 33901765 DOI: 10.1016/j.thromres.2021.04.011] [Reference Citation Analysis]
16 Gemmati D, Burini F, Talarico A, Fabbri M, Bertocco C, Vigliano M, Moratelli S, Cuneo A, Serino ML, Avato FM, Tisato V, Gaudio RM. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study. PLoS One 2016;11:e0162084. [PMID: 27606428 DOI: 10.1371/journal.pone.0162084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Albrecht D, Turakhia MP, Ries D, Marbury T, Smith W, Dillon D, Milner PG, Midei MG. Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease. Thromb Haemost 2017;117:2026-33. [PMID: 28933798 DOI: 10.1160/TH16-10-0815] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
18 Tyson RJ, Park CC, Powell JR, Patterson JH, Weiner D, Watkins PB, Gonzalez D. Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables. Front Pharmacol 2020;11:420. [PMID: 32390828 DOI: 10.3389/fphar.2020.00420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
19 Mohammadi K, Kargar M. Sensitivity to warfarin following cardiac surgery. Ther Adv Drug Saf 2018;9:673-4. [PMID: 30546861 DOI: 10.1177/2042098618804488] [Reference Citation Analysis]